Research Paper Volume 11, Issue 18 pp 7525—7536

Identification of a novel microRNA recurrence-related signature and risk stratification system in breast cancer

class="figure-viewer-img"

Figure 2. miRNA-based prognostic model to predict 5-year disease-free survival in breast cancer patients.